Phone Number : +86 13989889852
WhatsApp : +008613989889852
June 9, 2022
UK(DHSC phase 3A) Passed - AllTest SARS-CoV-2 Antigen Rapid Test (Nasal Swab)
Good News From AllTest!
Since its establishment in August 2020, the joint UK Health Security Agency (UKHSA) Porton Down and University of Oxford SARS-CoV-2 lateral flow antigen test validation cell has evaluated over 160 lateral flow devices that have been referred by the Department of Health and Social Care.
Approximately 30% of the tests that were referred for validation met the standards for phase 2 valida-tion, which are set out in the protocol for evaluation of rapid diagnostic assays for specific SARS-CoV-2 antigens.
UKHSA Porton Down subsequently performed phase 3 testing to assess whether the lateral flow devic-es that passed phase 2 displayed performance characteristics desirable for mass population, communi-ty-based testing.
The Covid-19 Rapid Test products manufactured by AllTest Bio. has been successfully certified by UK Health Security Agency for its high accuracy rate and reputation for quality.
The desirable performance characteristics are:
· Very high specificity
· Very high sensitivity against viral loads associated with infectiousness
AllTest SARS-COV-2 Antigen Rapid Test has successfully passed the phase 3 testing in May 2022 with proven high accurate results.
Committed to the protection of people's health, the AllTest R&D team will always strive to develop and produce high quality testing reagents! Trust Us—Your reliable POCT Partner.